General Information of the Compound
Compound ID
CP0296225
Compound Name
2-{[2-(phenylamino)pyrimidin-4-yl]amino}benzamide
    Show/Hide
Synonyms
2-(2-(phenylamino)pyrimidin-4-ylamino)benzamide
4-anilinopyrimidine 2a
BDBM15995
CHEMBL428213
    Show/Hide
Structure
Formula
C17H15N5O
Molecular Weight
305.341
Canonical SMILES
NC(=O)c1ccccc1Nc1ccnc(Nc2ccccc2)n1
    Show/Hide
InChI
InChI=1S/C17H15N5O/c18-16(23)13-8-4-5-9-14(13)21-15-10-11-19-17(22-15)20-12-6-2-1-3-7-12/h1-11H,(H2,18,23)(H2,19,20,21,22)
    Show/Hide
InChIKey
TVKTVNQGZQPCAT-UHFFFAOYSA-N
Physicochemical Property
logP
3.0627
Rotatable Bonds
5
Heavy Atom Count
23
Polar Areas
92.93
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
5
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 23647253
ChEMBL ID
CHEMBL428213
Clinical Information about the Compound
Drug 1 ( 2-(2-(phenylamino)pyrimidin-4-ylamino)benzamide )
Drug Name 2-(2-(phenylamino)pyrimidin-4-ylamino)benzamide
Target(s)
Stress-activated protein kinase JNK1 (JNK1)
Inhibitor